Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.59 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | HPRT1 | P00492 | 3/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17103144 | 1.00 | ALDH1A1 (0.59) | ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2 | |
| SCHEMBL27980290 | 0.94 | ALDH1A1 (0.48) | ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2 | |
| SCHEMBL28814502 | 0.94 | ALDH1A1 (0.48) | ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2 | |
| SCHEMBL398847 | 0.89 | ALDH1A1 (0.52) | ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2 | |
| SCHEMBL1168307 | 0.89 | ALDH1A1 (0.52) | ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2 | |
| SCHEMBL18221939 | 0.89 | ALDH1A1 (0.64) | ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2 | |
| SCHEMBL508946 | 0.84 | ALDH1A1 (0.37) | ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2 | |
| Water SCHEMBL28067574 | 0.84 | ALDH1A1 (0.84) | ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2 | |
| SCHEMBL18529 | 0.84 | ALDH1A1 (0.37) | ALDH1A1HSD17B10HIF1ACYP1A2HPGD | |
| SCHEMBL3775172 | 0.82 | ALDH1A1 (0.45) | ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019076198-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | 北京鼎材科技有限公司 | 2019-04-25 | — | — | WO | claimed |
| US-8101290-B2 | Organic compound having electron-transporting and/or hole-blocking performance and its use and OLEDs comprising the compound | TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY OF CHINESE ACADEMY OF SCIENCES (CN) | 2012-01-24 | — | — | US | claimed |
| US-20090102356-A1 | NOVEL ORGANIC COMPOUND HAVING ELECTRON-TRANSPORTING AND/OR HOLE-BLOCKING PERFORMANCE AND ITS USE AND OLEDs COMPRISING THE COMPOUND | TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY OF CHINESE ACADEMY OF SCIENCES (CN) | 2009-04-23 | — | — | US | claimed |
| WO-2024114085-A1 | TRIARYLAMINE ORGANIC COMPOUND AND USE THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE | 北京鼎材科技有限公司 | 2024-06-06 | — | — | WO | disclosed |
| US-20240026149-A1 | CURING AGENT, METHOD OF PRODUCING CURING AGENT, AND CURABLE COMPOSITION | DEXERIALS CORPORATION (JP) | 2024-01-25 | — | — | US | disclosed |
| WO-2024012365-A1 | ORGANIC COMPOUND AND USE THEREOF | 清华大学 | 2024-01-18 | — | — | WO | disclosed |
| US-20230422617-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS | KUNSHAN GO-VISIONOX OPTO-ELECTRONICS CO., LTD (CN) | 2023-12-28 | — | — | US | disclosed |
| EP-4291000-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS | Kunshan Go-Visionox Opto-Electronics Co., Ltd. (CN) | 2023-12-13 | — | — | EP | disclosed |
| US-11795264-B2 | Latent curing agent and method for manufacturing same, composition for forming coating film, and cation-curable composition | DEXERIALS CORPORATION (JP) | 2023-10-24 | — | — | US | disclosed |
| WO-2023095601-A1 | LATENT CURING AGENT AND METHOD FOR PRODUCING SAME, AND CURABLE COMPOSITION | デクセリアルズ株式会社 | 2023-06-01 | — | — | WO | disclosed |
| WO-2023282174-A1 | CURABLE COMPOSITION, AND CURED PRODUCT | デクセリアルズ株式会社 | 2023-01-12 | — | — | WO | disclosed |
| US-8198342-B2 | Aluminum chelate latent curing agent and production method thereof | SONY CHEMICAL AND INFORMATION DEVICE CORPORATION (JP) | 2012-06-12 | — | — | US | disclosed |
| US-8101290-B2 | Organic compound having electron-transporting and/or hole-blocking performance and its use and OLEDs comprising the compound | TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY OF CHINESE ACADEMY OF SCIENCES (CN) | 2012-01-24 | — | — | US | disclosed |
| US-20110196110-A1 | ALUMINUM CHELATE LATENT CURING AGENT AND PRODUCTION METHOD THEREOF | SONY CHEMICAL & INFORMATION DEVICE CORPORATION (JP) | 2011-08-11 | — | — | US | disclosed |
| US-20100331435-A1 | ALUMINUM CHELATE LATENT CURING AGENT AND PRODUCTION METHOD THEREOF | SONY CHEMICAL & INFORMATION DEVICE CORP. (JP) | 2010-12-30 | — | — | US | disclosed |
| US-20090102356-A1 | NOVEL ORGANIC COMPOUND HAVING ELECTRON-TRANSPORTING AND/OR HOLE-BLOCKING PERFORMANCE AND ITS USE AND OLEDs COMPRISING THE COMPOUND | TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY OF CHINESE ACADEMY OF SCIENCES (CN) | 2009-04-23 | — | — | US | disclosed |
| CN-101348484-A | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these | NOVALED AG (DE) | 2009-01-21 | — | — | CN | disclosed |
| EP-1357936-A4 | BIOCATALYTIC AND BIOMIMETIC GENERATION OF NITRIC OXIDE i IN SITU /i AT SUBSTRATE/BLOOD INTERFACES | UNIV MICHIGAN (US) | 2005-08-10 | — | — | EP | disclosed |
| EP-1357936-A1 | BIOCATALYTIC AND BIOMIMETIC GENERATION OF NITRIC OXIDE i IN SITU /i AT SUBSTRATE/BLOOD INTERFACES | THE BOARD OF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2003-11-05 | — | — | EP | disclosed |
| WO-2002056904-A1 | BIOCATALYTIC AND BIOMIMETIC GENERATION OF NITRIC OXIDE IN SITU AT SUBSTRATE/BLOOD INTERFACES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2002-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090102356-A1 | NOVEL ORGANIC COMPOUND HAVING ELECTRON-TRANSPORTING AND/OR HOLE-BLOCKING PERFORMANCE AND ITS USE AND OLEDs COMPRISING THE COMPOUND | SLCO4C1, SLCO1B1, SLCO2B1 | ALDH1A1 2684/4885HSD17B10 1708/4885CYP1B1 1445/4885 |
| US-20230422617-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS | OCIAD1, OCIAD2, EML4 | ALDH1A1 86/4885HSD17B10 2923/4885CYP1B1 3039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.